Efficacy of Anti-TNFα in Severe and Refractory Neuro-Behcet Disease: An Observational Study
To report the safety and efficacy of anti-tumor necrosis factor α (TNFα) therapy in severe and refractory neuro-Behçet disease (NBD) patients.
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Wolters Kluwer Health
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907644/ |